June 7th, 2016 – Rescue Hearing Inc. (RHI), a leader in innovative gene therapies for hearing loss, is proud to announce the appointment of Dr. Hinrich Staecker, MD, PhD, to its Scientific Advisory Board. A distinguished leader in otology, neurotology, and hearing restoration research at the University of Kansas Medical Center, Dr. Staecker brings extensive expertise in gene therapy, inner ear drug delivery, and regenerative medicine to advance RHI’s mission of delivering curative treatments.

A Scientific Leader Joining Forces with Rescue Hearing

Dr. Staecker’s groundbreaking work as the David and Mary Zamierowsky Professor of Otolaryngology has yielded significant advances, including:

• Pioneering research in hair cell regeneration and novel hearing loss treatments.
• Innovative approaches to inner ear drug delivery systems.
• Translational techniques to enhance auditory restoration—complementing gene therapy approaches.

His dual role as a clinician and translational researcher bridges the gap between laboratory discoveries and clinical applications, aligning perfectly with RHI’s focus on clinical-stage gene therapies.

Accelerating Therapeutic Development

With extensive experience in clinical trial design and regulatory pathways, Dr. Staecker will play a crucial role in advancing RHI’s pipeline toward commercialization. His leadership on multiple NIH-funded grants and collaborations with academia and industry underscore RHI’s strategy to fast-track therapies for genetic and acquired hearing loss.

“Dr. Staecker’s deep expertise in hearing restoration is a tremendous asset to our team,” said Jim Ayala, CEO/Founder of Rescue Hearing Inc. “His clinical insights and research leadership will help advance our efforts to bring meaningful solutions to those with hearing loss.”

A Shared Vision for the Future

With 1.5 billion people globally affected by hearing loss, RHI and Dr. Staecker’s partnership represents a significant step toward innovative restorative therapies. Investors and collaborators are invited to join this critical mission.

Contact Information